Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Cryopreservation Market

Cell Cryopreservation Market Share

Report ID: GMI7882
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Cell Cryopreservation Market Share

The cell cryopreservation industry is consolidated, with key players including Thermo Fisher Scientific Inc., Sartorius AG, GE Healthcare, Danaher Corporation, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares.

For instance, in July 2023, Sartorius opened a manufacturing facility for cell culture media in Puerto Rico. These media played a crucial role in producing therapeutic proteins and various modalities. This development enhanced Sartorius manufacturing capacity along with extensive portfolio, particularly in the North & South America region.

Cell Cryopreservation Market Companies

Some of the eminent market participants operating in the cell cryopreservation industry include:

Thermo Fisher Scientific Inc.
Sartorius AG
PromoCell GmbH
BioLife Solutions Inc.
Merck KGaA
HiMedia Laboratories
Creative Biolabs
Corning Incorporated
GE Healthcare
Danaher Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cell cryopreservation industry was valued at USD 10.4 billion in 2023 and is estimated to reach USD 57.6 billion by 2032, driven by the emergence of new applications for stem cells in disease treatment, augmented investment in the management of chronic diseases, the rising acceptance of stem cell therapeutics, etc.

The equipment segment garnered USD 7.5 billion in 2023 and is growing significantly through 2032 as automated systems are gaining prominence for their ability to streamline workflows, minimize manual errors, and significantly enhance the overall efficiency of processes related to cell banking and storage.

U.S. cell cryopreservation market accounted for USD 4.3 billion in 2023 and is predicted to witness substantial growth over 2024-2032 as the nation is a global hub for biotechnology and pharmaceutical research and development.

Thermo Fisher Scientific Inc., Sartorius AG, PromoCell GmbH, BioLife Solutions Inc., Merck KGaA, HiMedia Laboratories, Creative Biolabs, Corning Incorporated, GE Healthcare, and Danaher Corporation.